Table 2. Correlations between HR-HPV and STIs with abnormal cervical cytology.
Variable | NILM | ASC-US | LSIL | ASC-H | HSIL | p-value | |
---|---|---|---|---|---|---|---|
HR-HPV | <0.001 | ||||||
Negative* | 179 (89.5) | 96 (48.0) | 30 (15.0) | 27 (13.5) | 12 (6.0) | ||
Positive† | 21 (10.5) | 104 (52.0) | 170 (85.0) | 173 (86.5) | 188 (94.0) | ||
Total STIs | 0.018 | ||||||
Negative | 88 (44.0) | 69 (34.5) | 62 (31.0) | 61 (30.5) | 61 (30.5) | ||
Positive | 112 (56.0) | 131 (65.5) | 138 (69.0) | 139 (69.5) | 139 (69.5) | ||
Chlamydia trachomatis | 0.080 | ||||||
Negative | 198 (99.0) | 196 (98.0) | 192 (96.0) | 189 (94.5) | 191 (95.5) | ||
Positive | 2 (1.0) | 4 (2.0) | 8 (4.0) | 11 (5.5) | 9 (4.5) | ||
Mycoplasma genitalicum | 0.022 | ||||||
Negative | 196 (98.0) | 199 (99.5) | 188 (94.0) | 194 (97.0) | 192 (96.0) | ||
Positive | 4 (2.0) | 1 (0.5) | 12 (6.0) | 6 (3.0) | 8 (4.0) | ||
Mycoplasma hominis | 0.777 | ||||||
Negative | 177 (88.5) | 172 (86.0) | 169 (84.5) | 169 (84.5) | 171 (85.5) | ||
Positive | 23 (11.5) | 28 (14.0) | 31 (15.5) | 31 (15.5) | 29 (14.5) | ||
Neisseria gonorrhea | 0.519 | ||||||
Negative | 200 (100.0) | 199 (99.5) | 200 (100.0) | 200 (100.0) | 198 (99.0) | ||
Positive | 0 | 1 (0.5) | 0 | 0 | 2 (1.0) | ||
Trichomonas vaginalis | 0.884 | ||||||
Negative | 199 (99.5) | 198 (99.0) | 198 (99.0) | 200 (100.0) | 199 (99.5) | ||
Positive | 1 (0.5) | 2 (1.0) | 2 (1.0) | 0 | 1 (0.5) | ||
Ureaplasma parvum | 0.488 | ||||||
Negative | 104 (52.0) | 94 (47.0) | 90 (45.0) | 91 (45.5) | 87 (43.5) | ||
Positive | 96 (48.0) | 106 (53.0) | 110 (55.0) | 109 (54.5) | 113 (56.5) | ||
Ureaplasma urealyticum | 0.055 | ||||||
Negative | 163 (81.5) | 157 (78.5) | 140 (70.0) | 157 (78.5) | 160 (80.0) | ||
Positive | 37 (18.5) | 43 (21.5) | 60 (30.0) | 43 (21.5) | 40 (20.0) | ||
Multiple infections | 0.014 | ||||||
Single | 68 (60.7) | 83 (63.4) | 65 (47.1) | 88 (63.3) | 91 (65.5) | ||
Multiple | 44 (39.3) | 48 (36.6) | 73 (52.9) | 51 (36.7) | 48 (34.5) |
Values are presented as number (%).
ASC-H, atypical squamous cells, cannot exclude high grade squamous intraepithelial lesion; ASC-US, atypical squamous cells of undetermined significance; HR-HPV, high-risk human papillomavirus; HSIL, high-grade squamous intraepithelial lesion; NILM, negative for intraepithelial lesion or malignancy; LSIL, low-grade squamous intraepithelial lesion; STI, sexually transmitted infection. *Negative for all micro-organisms of STI. †Positive for any microorganism of STI including multiple infections.